19113, Philadelphia, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 19113, Philadelphia, Pennsylvania is 90 when comparing 34,000 ZIP Codes in the United States.

An estimate of 0.00 percent of the residents in 19113 has some form of health insurance. 0.00 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 0.00 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 19113 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 0 residents under the age of 18, there is an estimate of 514 pediatricians in a 20-mile radius of 19113. An estimate of 105 geriatricians or physicians who focus on the elderly who can serve the 0 residents over the age of 65 years.

In a 20-mile radius, there are 103,327 health care providers accessible to residents in 19113, Philadelphia, Pennsylvania.

## Prostate Cancer Score Analysis: Doctors in ZIP Code 19113 & Primary Care Availability in Philadelphia

This analysis assesses the landscape of prostate cancer care within ZIP code 19113, a specific area within Philadelphia, and evaluates the broader context of primary care availability across the city. The goal is to provide a nuanced understanding of the resources available to men facing prostate cancer, considering factors beyond just the presence of specialists. We will delve into physician-to-patient ratios, highlight standout practices, explore telemedicine adoption, and examine the integration of mental health resources, ultimately offering a comprehensive "Prostate Cancer Score" perspective.

The foundation of effective prostate cancer care rests on accessible and high-quality primary care. In Philadelphia, the availability of primary care physicians (PCPs) significantly impacts the early detection and management of this disease. A robust primary care network facilitates regular screenings, patient education, and timely referrals to specialists. Unfortunately, Philadelphia, like many urban centers, faces challenges in primary care access. Physician shortages, particularly in underserved areas, can lead to longer wait times for appointments and potentially delay crucial diagnostic procedures. This scarcity of PCPs disproportionately affects vulnerable populations, hindering their access to preventative care and potentially impacting prostate cancer outcomes.

Within ZIP code 19113, the situation demands closer scrutiny. The physician-to-patient ratio is a critical indicator. This ratio, calculated by dividing the population of 19113 by the number of practicing PCPs in the area, offers a preliminary assessment of access. A higher ratio suggests a greater burden on each physician, potentially impacting the quality of care and the ability to provide personalized attention. Furthermore, the demographics of 19113, including age and socioeconomic status, should be considered. These factors can influence the prevalence of prostate cancer risk factors and the ability of residents to access and afford healthcare.

Beyond raw numbers, the quality of primary care is paramount. Standout practices within 19113 and the broader Philadelphia area should be identified. These practices often demonstrate excellence in several areas: patient satisfaction, preventative care protocols, and coordinated care. Features like extended hours, multilingual staff, and integrated behavioral health services can significantly improve patient experience and adherence to treatment plans. Practices that actively participate in research and clinical trials, particularly those focused on prostate cancer, should also be recognized for their commitment to advancing patient care.

The integration of telemedicine has emerged as a transformative force in healthcare delivery, and its adoption is particularly relevant in the context of prostate cancer. Telemedicine offers several advantages, including increased access to specialists, reduced travel time, and improved convenience for patients. Within 19113 and Philadelphia, the availability of telemedicine services for prostate cancer consultations, follow-up appointments, and patient education should be evaluated. Practices that embrace telemedicine can extend their reach and provide care to patients who might otherwise face significant barriers to accessing healthcare. The ease of use of these platforms, their integration with electronic health records, and the availability of technical support are crucial factors in their success.

Mental health is an often-overlooked aspect of prostate cancer care, yet it is critically important. A prostate cancer diagnosis and treatment can profoundly impact a man's emotional well-being, leading to anxiety, depression, and other psychological challenges. The availability of mental health resources within primary care practices and specialist offices is a key component of a comprehensive "Prostate Cancer Score." Practices that offer on-site counseling, referrals to mental health professionals, and support groups demonstrate a commitment to holistic patient care. The integration of mental health services helps patients cope with the emotional and psychological challenges associated with their diagnosis and treatment, improving their overall quality of life.

The "Prostate Cancer Score" for 19113 and Philadelphia should also consider the presence of support networks. Support groups, both in-person and online, provide invaluable peer-to-peer support for men with prostate cancer and their families. These groups offer a safe space to share experiences, learn coping strategies, and access information about treatment options. The availability and accessibility of these support networks are crucial elements of a comprehensive care system.

Furthermore, the "Prostate Cancer Score" must factor in the availability of resources for prostate cancer screening and treatment. This includes access to advanced diagnostic tools, such as MRI and PET scans, as well as the availability of various treatment options, including surgery, radiation therapy, and hormone therapy. The presence of experienced urologists and oncologists, as well as access to clinical trials, are also important considerations.

The ability to navigate the healthcare system is another critical factor. The "Prostate Cancer Score" should assess the availability of patient navigators or care coordinators who can assist patients in understanding their diagnosis, treatment options, and insurance coverage. These individuals play a vital role in ensuring that patients receive the care they need in a timely and efficient manner.

Ultimately, the "Prostate Cancer Score" is not a single number but a multifaceted assessment. It considers the availability of primary care, the physician-to-patient ratio, the quality of care, the adoption of telemedicine, the integration of mental health resources, the presence of support networks, and the availability of screening and treatment options. By evaluating these factors, we can gain a comprehensive understanding of the resources available to men in 19113 and Philadelphia who are facing prostate cancer.

To further explore the healthcare landscape of 19113 and Philadelphia, including physician locations, practice details, and the availability of resources, we encourage you to utilize interactive mapping tools.

**Call to Action:**

**Visualize the landscape of prostate cancer care in Philadelphia with CartoChrome maps. Explore physician locations, practice details, and resource availability to make informed decisions about your health.**